Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation.
Kaposi's sarcoma-associated herpesvirus (KSHV) causes several human diseases including Kaposi's sarcoma (KS), a leading cause of cancer in Africa and in patients with AIDS. KS tumor cells harbor KSHV predominantly in a latent form, while typically <5% contain lytic replicating virus. Be...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-09-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011169&type=printable |
| _version_ | 1827308752701751296 |
|---|---|
| author | Annabel T Olson Yuqi Kang Anushka M Ladha Songli Zhu Chuan Bian Lim Behnam Nabet Michael Lagunoff Taranjit S Gujral Adam P Geballe |
| author_facet | Annabel T Olson Yuqi Kang Anushka M Ladha Songli Zhu Chuan Bian Lim Behnam Nabet Michael Lagunoff Taranjit S Gujral Adam P Geballe |
| author_sort | Annabel T Olson |
| collection | DOAJ |
| description | Kaposi's sarcoma-associated herpesvirus (KSHV) causes several human diseases including Kaposi's sarcoma (KS), a leading cause of cancer in Africa and in patients with AIDS. KS tumor cells harbor KSHV predominantly in a latent form, while typically <5% contain lytic replicating virus. Because both latent and lytic stages likely contribute to cancer initiation and progression, continued dissection of host regulators of this biological switch will provide insights into fundamental pathways controlling the KSHV life cycle and related disease pathogenesis. Several cellular protein kinases have been reported to promote or restrict KSHV reactivation, but our knowledge of these signaling mediators and pathways is incomplete. We employed a polypharmacology-based kinome screen to identify specific kinases that regulate KSHV reactivation. Those identified by the screen and validated by knockdown experiments included several kinases that enhance lytic reactivation: ERBB2 (HER2 or neu), ERBB3 (HER3), ERBB4 (HER4), MKNK2 (MNK2), ITK, TEC, and DSTYK (RIPK5). Conversely, ERBB1 (EGFR1 or HER1), MKNK1 (MNK1) and FRK (PTK5) were found to promote the maintenance of latency. Mechanistic characterization of ERBB2 pro-lytic functions revealed a signaling connection between ERBB2 and the activation of CREB1, a transcription factor that drives KSHV lytic gene expression. These studies provided a proof-of-principle application of a polypharmacology-based kinome screen for the study of KSHV reactivation and enabled the discovery of both kinase inhibitors and specific kinases that regulate the KSHV latent-to-lytic replication switch. |
| first_indexed | 2024-03-11T21:53:49Z |
| format | Article |
| id | doaj.art-7bdbcc8d08244e078bda190c159e2904 |
| institution | Directory Open Access Journal |
| issn | 1553-7366 1553-7374 |
| language | English |
| last_indexed | 2024-04-24T19:16:27Z |
| publishDate | 2023-09-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Pathogens |
| spelling | doaj.art-7bdbcc8d08244e078bda190c159e29042024-03-26T05:34:55ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742023-09-01199e101116910.1371/journal.ppat.1011169Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation.Annabel T OlsonYuqi KangAnushka M LadhaSongli ZhuChuan Bian LimBehnam NabetMichael LagunoffTaranjit S GujralAdam P GeballeKaposi's sarcoma-associated herpesvirus (KSHV) causes several human diseases including Kaposi's sarcoma (KS), a leading cause of cancer in Africa and in patients with AIDS. KS tumor cells harbor KSHV predominantly in a latent form, while typically <5% contain lytic replicating virus. Because both latent and lytic stages likely contribute to cancer initiation and progression, continued dissection of host regulators of this biological switch will provide insights into fundamental pathways controlling the KSHV life cycle and related disease pathogenesis. Several cellular protein kinases have been reported to promote or restrict KSHV reactivation, but our knowledge of these signaling mediators and pathways is incomplete. We employed a polypharmacology-based kinome screen to identify specific kinases that regulate KSHV reactivation. Those identified by the screen and validated by knockdown experiments included several kinases that enhance lytic reactivation: ERBB2 (HER2 or neu), ERBB3 (HER3), ERBB4 (HER4), MKNK2 (MNK2), ITK, TEC, and DSTYK (RIPK5). Conversely, ERBB1 (EGFR1 or HER1), MKNK1 (MNK1) and FRK (PTK5) were found to promote the maintenance of latency. Mechanistic characterization of ERBB2 pro-lytic functions revealed a signaling connection between ERBB2 and the activation of CREB1, a transcription factor that drives KSHV lytic gene expression. These studies provided a proof-of-principle application of a polypharmacology-based kinome screen for the study of KSHV reactivation and enabled the discovery of both kinase inhibitors and specific kinases that regulate the KSHV latent-to-lytic replication switch.https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011169&type=printable |
| spellingShingle | Annabel T Olson Yuqi Kang Anushka M Ladha Songli Zhu Chuan Bian Lim Behnam Nabet Michael Lagunoff Taranjit S Gujral Adam P Geballe Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation. PLoS Pathogens |
| title | Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation. |
| title_full | Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation. |
| title_fullStr | Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation. |
| title_full_unstemmed | Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation. |
| title_short | Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation. |
| title_sort | polypharmacology based kinome screen identifies new regulators of kshv reactivation |
| url | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011169&type=printable |
| work_keys_str_mv | AT annabeltolson polypharmacologybasedkinomescreenidentifiesnewregulatorsofkshvreactivation AT yuqikang polypharmacologybasedkinomescreenidentifiesnewregulatorsofkshvreactivation AT anushkamladha polypharmacologybasedkinomescreenidentifiesnewregulatorsofkshvreactivation AT songlizhu polypharmacologybasedkinomescreenidentifiesnewregulatorsofkshvreactivation AT chuanbianlim polypharmacologybasedkinomescreenidentifiesnewregulatorsofkshvreactivation AT behnamnabet polypharmacologybasedkinomescreenidentifiesnewregulatorsofkshvreactivation AT michaellagunoff polypharmacologybasedkinomescreenidentifiesnewregulatorsofkshvreactivation AT taranjitsgujral polypharmacologybasedkinomescreenidentifiesnewregulatorsofkshvreactivation AT adampgeballe polypharmacologybasedkinomescreenidentifiesnewregulatorsofkshvreactivation |